Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMBKJL1)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Cloperastine hydrochloride; 14984-68-0; Seki; Cloperastine HCl; Cloperastina cloridrato [Italian]; EINECS 239-067-8; 1-(2-((4-Chlorophenyl)(phenyl)methoxy)ethyl)piperidine hydrochloride; 2-Piperidinoethyl p-chlorobenzhydryl ether hydrochloride; 1-(2-((p-Chloro-alpha-phenylbenzyl)oxy)ethyl)piperidine hydrochloride; 1-(2-(p-Cloro-alpha-fenilbenzilossi)etil)piperidina cloridrato [Italian]; DSSTox_RID_80863; DSSTox_CID_25413; DSSTox_GSID_45413; Q-200881; 4-Chlorobenzhydryl 2-(1-Piperidyl)ethyl Ether Hydrochloride
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Bone
Osteosarcoma
Breast
Breast adenocarcinoma
Prostate
Prostate carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
